Athira Pharma, Inc.
NASDAQ:ATHA
0.73 (USD) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.969 | 1.048 | 0.479 | 2 | 0 | 0 |
| Gross Profit
| -0.969 | -1.048 | -0.479 | -2 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 93.79 | 61.464 | 42.794 | 13.286 | 3.793 | 3.589 |
| General & Administrative Expenses
| 33.304 | 32.552 | 21.228 | 6.709 | 1.656 | 1.42 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 33.304 | 32.552 | 21.228 | 6.709 | 1.656 | 1.42 |
| Other Expenses
| -1.628 | -5.161 | -8.835 | -1.321 | -0.754 | -0.164 |
| Operating Expenses
| 125.466 | 88.855 | 55.187 | 18.674 | 4.695 | 5.009 |
| Operating Income
| -125.466 | -104.016 | -64.022 | -19.995 | -5.449 | -5.009 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 7.794 | 8.377 | 9.169 | 0.04 | 0.288 | -0.088 |
| Income Before Tax
| -117.672 | -95.639 | -54.853 | -19.955 | -5.161 | -5.097 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -1.628 | -8.377 | -0.479 | -1.321 | -0.459 | -0.076 |
| Net Income
| -117.672 | -87.262 | -54.374 | -18.634 | -4.702 | -5.097 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -3.1 | -2.31 | -1.47 | -0.57 | -0.14 | -0.82 |
| EPS Diluted
| -3.09 | -2.31 | -1.47 | -0.57 | -0.14 | -0.82 |
| EBITDA
| -116.703 | -94.591 | -54.371 | -19.012 | -4.815 | -0.079 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |